- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20.05. | Samsung Bioepis Launches Ustekinumab Biosimilar in Japan | ||
| 20.05. | Oxford Nanopore and Lonza Launch mRNA QC Solution for GMP Testing | ||
| 20.05. | Curia Upgrades Aseptic Suites in Valladolid, Spain | ||
| 20.05. | BMS to Deploy Claude Agentic AI Across 30,000 Employees | ||
| 20.05. | Fujifilm Cellular Dynamics Opens New Headquarters & iPSC Manufacturing Facility in Madison | ||
| 19.05. | Passkey Therapeutics Taps Mandeep Kaur as Chief Medical Officer | ||
| 19.05. | Cosette Pharmaceuticals Names David Bell CCO of Brands | ||
| 19.05. | Incyte to Deploy Edison Scientific's AI Scientist Kosmos for R&D | ||
| 19.05. | ATB Therapeutics Names Mark Throsby as CEO | ||
| 19.05. | Vistagen Taps Dr. Angel Angelov as Chief Medical Officer | ||
| 19.05. | Hansa Biopharma Signs IDEFIRIX Licensing Deal With SERB | ||
| 19.05. | Helio Genomics Partners with Syneos Health to Drive Awareness & Adoption of HelioLiver | ||
| 18.05. | AstraZeneca Hypertension Treatment Baxfendy Approved by FDA | ||
| 18.05. | Orca Bio Taps Bijan Nejadnik as New Chief Medical Officer | ||
| 18.05. | Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9B | ||
| 18.05. | AstraZeneca, Daiichi Sankyo's Enhertu Gets New US Approval for Two HER2-Positive Breast Cancer Indications | ||
| 18.05. | ProtaGene Teams With MilliporeSigma on End-to-End Testing | ||
| 18.05. | Triana Biomedicines Taps Dr. Mohan Bala as Chief Operating Officer | ||
| 18.05. | Piramal Pharma Solutions, Botanix Partner to Support Drug Substance Development | ||
| 18.05. | FDA Approves First Simponi Biosimilars in U.S. | ||
| 18.05. | Parabilis Medicines, Regeneron Partner to Advance Novel Antibody-Helicon Conjugates | ||
| 15.05. | Veracyte Gains Medicare Coverage for Muscle-Invasive Bladder Cancer Recurrence Monitoring Test | ||
| 15.05. | Valar Labs Gets FDA Breakthrough Device Nod for Vesta Bladder Cancer Risk Test | ||
| 15.05. | Telix to Explore PSMA-PET Imaging in Collaborations with EDAP TMS and Profound | ||
| 14.05. | Terumo BCT, Steminent Join to Accelerate Late-Stage Clinical Manufacturing for Mesenchymal Stem Cell Therapies |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.